Key Employees A list of the key executives of the company. Business Description A brief description of the company's operations. Each such deal has a brief summary, deal type, deal rationale and deal financials and target Company's major public companies key financial metrics and ratios. Major Deals Information on the company's major financial deals. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Scopeįinancial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. CLC bio AS Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The company has operations in India, Japan, Denmark, Taiwan, and the US. It offers consultation services such as customization, integration, scientific applications and customer projects and also provides support services including documentation and training. CLC's product portfolio comprises of desktop software, enterprise software, genomics machines and microbial genome finishing modules. The company's analyses are available in graphical interface and commandline formats.
#CLC BIO SOFTWARE SOFTWARE#
Its analysis platform integrates desktop and server software and optimizes them for better performance. Home » Topics » DNA sequencing » Latest News » CLC bio AS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250ĬLC bio A/S CLC, a subsidiary of Qiagen N.V., is a bioinformatics software company that designs and develops comprehensive computing solutions and userfriendly analysis packages for analyzing, comparing, and visualizing next generation sequencing data. CLC bio AS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25072017 Prices from USD $250
0 kommentar(er)
